9 September 2013 - Deborah Wilkes
Archived
GlaxoSmithKline has agreed to sell its Lucozade and Ribena nutritional drinks brands to Japan's Suntory Beverage & Food for £1.35 billion (US$2.15 billion) in cash.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.